FIP-glu can inhibit a variety of tumors; for example, it promotes apoptosis with the enhancement of caspase-3 activity in human leukemia cells [58], inhibits the growth of lung cancer cells via p53-dependent G1 arrest [59], and suppresses the viability of mouse melanoma cells [60]. This evidence concerns the gene TP53 and lung carcinoma.